RxDoctor Payments Data

Joseph Hadeed, MD

Geriatric Medicine · Parkland, FLNPI 1912999061

Payments from drug & device makers

$1,383in general payments, 2019–2025

Across 20 payments — averaging $69.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$639
  • Innovation Technologies Inc$198
  • Motiva USA, LLC$137
  • Tepha Inc$136
  • Eisai Inc.$122
  • AbbVie$112
  • plus $39 from 2 others

What the payments were for

  • Food & beverage$1,383100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,383 in reported general payments places this provider in the 75th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$276,728
Medicare patients
350
Services billed
2,267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban122$97,457
XareltoRivaroxaban37$31,099
JardianceEmpagliflozin19$26,117
FarxigaDapagliflozin Propanediol26$20,452
MyrbetriqMirabegron27$16,081
Breo ElliptaFluticasone/Vilanterol32$15,591
OzempicSemaglutide17$12,734
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,868
EntrestoSacubitril/Valsartan14$8,449
Memantine Hcl108$6,535
Levothyroxine Sodium454$5,766
GemtesaVibegron11$5,544
Rosuvastatin Calcium189$4,995
Atorvastatin Calcium384$4,959
Pantoprazole Sodium260$4,951

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$639$31,09937 claims
Novo NordiskOzempic$18$12,73417 claims
AbbVieSynthroid$112$2,93750 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Parkland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →